Adaptyv is building an automated lab thats let AI agents run biology experiments. Were entering the era of agentic science where AI models can now design novel proteins, propose hypotheses, and iterate on experimental results. But
The Analytical Strategy Director is a key scientific and strategic leadership role. In this position you will be responsible for developing and driving analytical strategies that support drug discovery, development, and regulatory approval. The position ensures
Company Description Statistics show that women and underrepresented groups tend to apply to jobs only if they meet 100% of the qualifications. Sobi encourages you to change that statistic and apply. Rarely do candidates meet 100%
Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle
BandLevel 5 Job Description SummaryLocation: Basel, Switzerland; #LI-Hybrid 3 days/week in office Internal job title: Associate Director, Agentic AI Solutions Product Manager About the Role: We are seeking a Product Manager Agentic AI Solutions to lead
At Ecolab, we offer you the opportunity to expand your skills and professional experience while collaborating with worldwide experts in water treatment. As a junior process engineer, you will be under guidance of more senior engineers
At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our
The Bachem Group is investing in a new site in Sisslerfeld in Northwestern Switzerland. This step is part of our long-term strategy to expand production capacity. The new production site will play a central role in
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
The Bachem Group is investing in a new site in Sisslerfeld in Northwestern Switzerland. This step is part of our long-term strategy to expand production capacity. The new production site will play a central role in
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
We are recruiting a Manufacturing Science and Technology (MSAT) Senior Scientist at our headquarters and biotech production site in Geneva. Reporting to the Head of MSAT, as part of a team of five and working cross-functionally with
Adaptyv is building an automated lab thats let AI agents run biology experiments. Were entering the era of agentic science where AI models can now design novel proteins, propose hypotheses, and iterate on experimental results. But
Adaptyv is building an automated lab thats let AI agents run biology experiments. Were entering the era of agentic science where AI models can now design novel proteins, propose hypotheses, and iterate on experimental results. But
Adaptyv is building an automated lab thats let AI agents run biology experiments. Were entering the era of agentic science where AI models can now design novel proteins, propose hypotheses, and iterate on experimental results. But
Adaptyv is building an automated lab thats let AI agents run biology experiments. Were entering the era of agentic science where AI models can now design novel proteins, propose hypotheses, and iterate on experimental results. But
This is Cradle Proteins are the molecular machines of life, used for many therapeutic, diagnostic, chemical, agricultural and food applications. Designing and optimizing proteins takes a lot of expert knowledge and manual effort, through the use
Adaptyv is building an automated lab thats let AI agents run biology experiments. Were entering the era of agentic science where AI models can now design novel proteins, propose hypotheses, and iterate on experimental results. But
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
We are rebuilding biotech for the AI era. When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps.